Status:
WITHDRAWN
Effect of PTH(1-34) Treatment on Fracture Healing in Vivo
Lead Sponsor:
Glostrup University Hospital, Copenhagen
Collaborating Sponsors:
The Danish Medical Research Council
Conditions:
Shoulder Fractures
Trochanteric Fractures
Eligibility:
FEMALE
50-85 years
Phase:
PHASE2
Brief Summary
The purpose of the study is to investigate, whether PTH(1-34) is able to promote fracture healing in postmenopausal women with fractures of the hip or shoulder.
Eligibility Criteria
Inclusion
- Acute new osteoporotic trochanteric or collum chirurgicum fracture
- Postmenopause
Exclusion
- Calcium metabolic disease other than osteoporosis
- Diseases known to affect calcium homeostasis
- Dementia
- Hypersensitivity to drug or other components of medication
- pre-existing hypercalcemia
- Decreased kidney function
- Increased alkaline phosphatase
- Prior external radiation therapy or brachytherapy of the skeleton
- Skeletal malignancies or bone metastases
- Alcohol and/or drug abuse
- Systemic treatment with corticosteroids within the last four weeks
- Non-cooperating patients
- Patients who do not speak and understand the danish language
Key Trial Info
Start Date :
October 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2010
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00741182
Start Date
October 1 2008
End Date
September 1 2010
Last Update
March 18 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Center for Ageing and Osteoporosis, Glostrup University Hospital
Copenhagen, Denmark